Revolutionary hepatitis C therapy now available for children in Poland
Children infected with the hepatitis C virus (HCV) now have access to the most advanced treatment available. This major breakthrough is the result of the PANDAA-PED study, led by Professor Maria Pokorska-Śpiewak of the Department of Pediatric Infectious Diseases at the Medical University of Warsaw. The study demonstrated 100% efficacy of the treatment, confirmed its safety, and showed no adverse effects on children’s development both during and after therapy.
Children infected with the hepatitis C virus (HCV) now have access to the most advanced treatment available. This major breakthrough is the result of the PANDAA-PED study, led by Professor Maria Pokorska-Śpiewak of the Department of Pediatric Infectious Diseases at the Medical University of Warsaw. The study demonstrated 100% efficacy of the treatment, confirmed its safety, and showed no adverse effects on children’s development both during and after therapy.

Revolutionary hepatitis C therapy now available for children in Poland

Children infected with the hepatitis C virus (HCV) now have access to the most advanced treatment available. This major breakthrough is the result of the PANDAA-PED study, led by Professor Maria Pokorska-Śpiewak of the Department of Pediatric Infectious Diseases at the Medical University of Warsaw. The study demonstrated 100% efficacy of the treatment, confirmed its safety, and showed no adverse effects on children’s development both during and after therapy.
Focus on MUW
Life at MUW

Multiculturalism
Every year MUW educates almost 800 students from all over the world, they gain their medical knowledge in an environment which respects cultural, racial and religious differences. This combination of different experiences, values and lifestyles creates a friendly international Academic Community at the Medical University of Warsaw.